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1  Introduction
Amyotrophic Lateral Sclerosis (ALS) is a rare progressive 
neurodegenerative disorder with an incidence of 2.1 per 
100 000 person-years and an estimated prevalence of 
5.4  cases per 100 000 population [1]. This progressive 
disease is characterized by a selective degeneration 
of both upper and lower motor neurons in the brain, 
brainstem, and spinal cord resulting in paralysis due to 
muscle weakness and atrophy. ALS usually leads to death 
in 3 to 5 years upon  the onset of symptoms [2]. Two forms 
of ALS can be recognized: the sporadic (SALS) accounts 
for 90−95% of the cases, while the familial form (FALS) 
accounts for the remaining 5−10% [3]. Both forms show 
similar clinical features suggesting a common pathogenic 
pathway. ALS is the most common disorder among motor 
neuron diseases with adult onset. Despite extensive 
research, its etiology is still unknown. Mutations in 
several genes, including SOD1, FUS and TARDBP, have 
been identified as responsible for the disease in 25-35% of 
cases of the familial forms [4-6]. Recently, the pathogenic 
expansion of a non-coding hexanucleotide repeat 
sequence (GGGGCC) in the C9ORF72 gene was reported in 
familial and sporadic forms of ALS [7,8].
Other proposed pathogenic mechanisms involve 
protein aggregation, oxidative stress, impairment of 
mitochondrial function, transcription dysfunctions, 
alterations in the proteasome pathway, inflammation, 
excitotoxicity, and environmental influences [9]. Among 
the environmental factors, metals have been hypothesized 
to play a − still much un-clarified – role in ALS. Indeed, 
through the years many neurodegenerative disorders, 
such as Alzheimer Disease, Parkinson Disease and ALS, 
have been linked to iron and metal metabolism in a 
number of studies [10,11]. 
Transition metal-induced toxicity also has been 
proposed to be involved in the pathology [12] and different 
authors reported increased concentrations of metals, 
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as well as of proteins regulating their homeostasis, in 
ALS patients [13-15]. Metals are essential for different 
physiological processes and their concentrations must be 
strictly regulated since imbalance can lead to toxic effects. 
Environmental, occupational and nutritional levels of 
metals could influence their body concentrations and 
result in overload. 
In this work, we report on a small cohort of subjects 
affected by the sporadic form of ALS, originating from 
a restricted geographical area with a high prevalence of 
the disease. We evaluated concentrations of different 
metals in serum trying to establish a correlation with ALS, 
assuming that the limited geographical area would allow 
to assess the role played by specific chemical species in 
the environment and in the diet of the involved subjects.
2  Methods
The study enrolled seven patients (4 men and 3 women) 
and five controls (2 men and 3 women, age matched – 
69 years vs. 64 years – and living in the same geographical 
area) (Table 1 and Table 2). All patients and controls were 
recruited by Medical Genetics Unit of Niguarda Ca’ Granda 
Hospital and signed an informed consent approved 
by local ethics committee. Controls were represented 
by caregivers of the patients, known to be free from 
neurological disorders and living in the same geographic 
area. Blood was collected from all subjects. Serum was 
obtained by centrifugation after clotting and stored at 
-80°C.
ALS diagnosis was according El Escorial criteria [9] 
with clinically defined sporadic cases; one presenting 
bulbar form at the onset, while the six with spinal form. 
All subjects were under Riluzole treatment; two of them 
underwent Percutaneous Endoscopic Gastrostomy (PEG). 
For metal quantitation, samples were analyzed by 
ICP-MS (Bruker AURORA M90 ICP-MS). Serum was diluted 
1:20 with 0.05% Triton X-100 in MilliQ water. SeronomTM 
Trace Elements Serum L-1 was used to build appropriate 
calibration curves. An aliquot of a 2 mg L-1 of an internal 
standard solution (45Sc, 89Y, 159Tb) was added to both 
samples and standards to give a final concentration of 
20 μg L-1 of each element. Typical analysis interferences 
were removed by using Collision-Reaction-Interface (CRI) 
with an H2 flow of 70 mL min-1 through the skimmer cone.
Statistical analyses were carried out with Student’s 
t-Test and through multivariate statistical analyses tools, 
including Principal Component Analysis (PCA) and Auto 
Contractive Map algorithm (Auto-CM), a type of Artificial 
Neural Network (ANN) able to define the strength of the 
associations of each variable with all the others and to 
visually show the map of the main connections; this 
approach has already been applied to studies on the ALS 
disease [16].
3  Results
Serum concentrations of Cr, Fe, Ni, Cu, Zn, As, Se, Sr, 
Cd, Pb are reported in Table 3. A statistically significant 
difference between patients and controls was found for Ni 
Table 1: Minimum clinical data for ALS patients. LL: lower limbs, UL: upper limbs. Duration of disease is calculated as time passed from 
symptoms onset to blood sampling or PEG start.
ID Gender Age at onset (y) Site at onset Duration of disease (y) PEG BMI at onset (m2 Kg-1) Occupation Smoke
1 SU M 48 LL 2.1 N 29.4 Shopkeeper N
2 SU M 57 Bulbar 3.0 Y 23.0 Manager Y
3 SU M 65 UL 3.2 N 28.1 Workman N
4 SU F 60 LL 19.1 N 22.9 Seamstress N
5 SU F 71 LL 12.1 N 27.9 Farmer N
6 SU M 69 LL 9.0 N 23.7 Manager N
7 SU F 59 LL 4.2 Y 29.3 Teacher EX
Table 2: Data for control subjects.
ID Gender Current age (y) BMI (m2 Kg-1) Occupation Smoke
244 N F 55 20.8 Odontologist N
245 N F 66 22.3 Teacher Y
246 N F 65 25.7 Housewife EX
247 N M 72 28.1 Professor N
248 N M 61 31.1 Manager EX
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(p = 0.0001), Pb (p = 0.01) and As (p = 0.05). The median 
Ni concentration was 9.44 μg L-1 for the ALS patients, about 
five times higher than in controls (2.14 μg L-1). The median 
Pb concentration in the patients’ group was almost twice 
that of controls (2.16 vs 1.26 μg L-1). Conversely, the median 
As concentration was lower in the patients’ group than 
in controls’ (0.51 μg L-1 vs 0.73 μg L-1). In both groups, Ni 
and Pb levels were higher than the values reported for 
the general Italian population. Indeed, according to data 
reported by the Italian Superior Health Institute [17], Ni 
concentrations should be in the 0.26−0.75 μg L-1 range, and 
Pb concentrations in the 0.20−0.98 μg L-1 range. 
Principal Component Analysis (PCA) was able to 
discriminate between the patients and the controls. The 
most prominent feature of the control group was a high 
concentration of As and a low concentrations of all the 
other metals analyzed. The semantic connectivity map 
generated with the Auto-CM system (Figure 1) confirmed 
this observation. This algorithm is able to visually show 
the connections between variables and to describe the 
strength of the connections with a numerical value 
from 0 to 1. Results clearly discriminate the two groups 
and define an ALS area characterized by high levels of 
metals, except for As. Among the three metals that were 
significantly different, none individually emerged as 
more relevant than the others in the discrimination of the 
controls’ group from the patients’ group. The Auto-CM 
analysis also indicated that high levels of Se were closely 
Table 3: Averages of the measures of metals concentrations in sera. *: p-value ≤ 0.05, NA: Not Available.
Element Average Patients  ± SD (μg L-1) Average Controls  ± SD (μg L-1) Reference Values (μg L-1) [17]
Cr 1.57 ± 0.12 1.54 ±0.06 0.07-0.28
Fe 1261.28 ± 429.00 1225.94 ± 160.00 648-1301
Ni 9.44 ± 1.02* 2.10 ± 0.92* 0.26-0.75
Cu 1130.24 ± 157.00 1141.55 ± 108 .00 648-1301
Zn 811.03 ± 114.00 835.88 ± 72.40 597-1028
As 0.51 ± 0.14* 0.73 ± 0.18* NA
Se 97.71 ± 10.20 89.54 ± 6.32 56-105
Sr 39.73 ± 12.50 34.54 ± 5.71 23-61.5
Cd 0.08 ± 0.03 0.06 ± 0.01 0.03-0.2
Pb 2.16 ± 0.72* 1.26 ± 0.29* 0.2-0.98
Figure 1: Semantic connectivity map obtained with Auto-Cm System. The Minimum Spanning Tree (MST) shows the connections between the 
variables. Values on the arches of the graph refer to the strength of the association between two adjacent nodes. The range of this value is 
Brought to you by | Università degli Studi di Milano
Authenticated
Download Date | 4/7/16 4:24 PM
32   S. De Benedetti, et al.
linked to the ALS group, whereas low levels of Se were 
connected with the controls. Even if Se levels did not 
reach statistical significance with common statistic tools 
(p = 0.12), artificial neural network multivariate statistical 
analyses point to a possible relevance of the observed 
differences (Figure 1).
4  Discussion
In the last decades, Amyotrophic Lateral Sclerosis has 
been the focus of intense research. Despite this, the 
etiology of the disease still has to be clarified. Genetic 
traits only partly explain this disorder [18] and, at 
present, fail to assess a common and clear molecular 
pattern that leads to the disease. Among subjects 
bearing a pathological mutation in one of the causative 
gene, a wide phenotypical heterogeneity is present [19], 
and this is true also in the sporadic form of the disease 
[20]. Clearly, some other factors must be involved in the 
pathogenesis of the disease; some of the triggers could be 
environmental influences [18]. We decided to focus our 
investigations on metals’ concentrations in a small group 
of subjects originating from a restricted geographical 
region due to the higher prevalence of the disease in this 
area, in comparison with literature data. In our intentions, 
limiting the investigation to a restricted area could help 
in pinpointing environmental or dietary contributions to 
specific metal species. 
We did not performed any study on environmental 
pollution, but we are aware of the presence of a steel plant 
within this area. Furthermore, there is a Cu and Fe mine, 
closed in 1962, located 8 km behind the inhabited area, 
within the basin of a creek, whose waters are reported to 
be strongly polluted due to Acid Mine Drainage. Waste-
rock dumps can store significant amounts of potentially 
deleterious metals that can be released to solutions 
during transformation processes, induced by variations in 
the physicochemical parameters or by ageing. This could 
lead to the release, to the circulating solutions, of high 
amounts of potentially toxic metals during weathering of 
sulfide mineralization (Fe, Cu, Zn, etc.) and host rocks (Cr, 
Ni, V, etc.) [21]. Among the metals analyzed, Pb resulted 
higher in patients’ than in controls’ group. Much evidence 
in the literature describes Pb as a neurotoxic agent and as 
being related to ALS [22,23], since high levels of this metal 
have been found both in blood and in cerebrospinal fluid 
of ALS patients [24,25]. In our analyses, Pb levels were 
twice higher in ALS subjects than in controls, supporting 
the hypothesis of a possible involvement of this metal in 
the etiology of the disease. 
Pb2+ ions have a substantial affinity for protein cysteine 
thiols, and could be involved in direct substitution of iron 
in various types of FeS clusters, a property that has been 
demonstrated in vitro for various thiophylic metals [26,27]. 
Rates and yields of cluster-metal substitution often depend 
on the redox state of the cluster iron [27,28] and on the 
accessibility of the ligands into the protein structure, as 
dictated by folding/unfolding rates and equilibria [27,29]. 
Another metal ion able to substitute for iron (in 
particular when ligands other than cysteine are involved) 
is Ni2+. In this study, Ni concentration was found almost 
five times higher in ALS patients than in controls. A 
Ni overload could promote oxidative stress and the 
production of Reactive Oxygen Species, as well as an 
increase in inflammatory markers [30]. However, recent 
evidence points to a direct role of Ni in the modulation 
of the biosynthetic pathways of FeS proteins in neural 
cells [31]. According to this report, high Ni2+ levels act by 
repressing the expression of the mitochondrial scaffold 
proteins IscU1 and IscU2, which are essential to FeS 
biogenesis [32]. According to this study, this leads to a 
cellular energy metabolism shift, likely as a result of an 
alteration in the mitochondrial respiratory chain and 
in the related energy fluxes [33]. The relevance of these 
issues is currently being investigated.
Arsenic can form both inorganic and organic 
compounds in the environment and in the human body, 
as either arsenite (As3+) or arsenate (As5+). Since absorbed 
arsenate is mostly reduced to arsenite in blood, the effect 
of the two forms appears to be very similar [30]. Many 
studies confirmed the generation of free radicals during 
As metabolism in cells, and oxidative stress has been 
linked to the development of As-related diseases [34]. In 
the light of this, the result obtained is unexpected, as the 
levels in our study controls were higher than in patients. 
One possible interpretation is that low levels of As are a 
feature of this peculiar group of ALS patients, without 
hypothesizing that an As overload may exert a protective 
role in control subjects. On the other hand, He and Ma 
reported that, in mouse hepa1c1c7 cells, As3+ induces the 
transcription of metallothionein I (MT1) through direct 
interaction with metal-activated transcription factor 1 
(MTF1) [35], and this could possibly result in a protective 
effect, in case of non-toxic levels of As overload. 
Auto-CM analysis also pointed to a possible 
relationship between ALS and Se levels in serum, 
although statistical significance was close to the limit of 
acceptability and expanding the number of subjects is 
still needed for verification. Abnormal levels of various 
Se species have been found in cerebrospinal fluid of ALS 
patients [36] and circulating levels of Se, usually bound to 
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serum albumin, could reflect the Se levels present in the 
Central Nervous System. Finally, we were not able to find 
a correlation between Fe levels and ALS in the group of 
patients considered in this study, although several reports 
previously assessed this relationship [14,37-39].
Despite these phenomenological reports, the role of 
these metals in the pathogenesis of ALS remains unclear. 
We plan to evaluate it in a wider cohort of subjects while 
investigating a broader panel of metals. Impaired metal 
homeostasis, hypothetically attributable to environmental 
exposure, in the end could lead to overload of different 
elements. Besides promoting oxidative stress, metals 
can compete for the binding sites of metals-containing 
proteins, such as those containing iron-sulfur clusters. 
This damaging effect could be exerted by all those metals 
having affinity for thiols, like mercury(II), silver(I), 
copper(I), lead(II), cadmium(II), nickel(II), zinc(II) and 
cobalt(II) whose toxicity in bacteria has been shown to be 
proportional to the affinity for sulfur [40]. 
The role of iron-sulfur clusters biosynthetic machinery 
in ALS is still poorly explored. Upregulation of Frataxin 
(Fxn) and of the human ortholog of the cluster-assembly 
scaffold protein (IscU), two of the proteins involved in 
carrying out or in regulating FeS biosynthesis, has been 
explained as a response of the cell to iron overload [38], 
whereas Ni overload results in the repression of IscU 
biosynthesis, as discussed above [31]. However, further 
investigation is required to assess a possible relationship 
between metal imbalance and the many biosynthetic 
steps leading to functional metalloproteins, as well as 
the molecular basis of mid- to long-term effects of metal 
imbalance on the energy status and the redox balance of 
neuronal cells. Effects on other proteins involved in metal 
homeostasis within the cytoplasm or in specific cellular 
compartments (such as metallothioneins or ferritin 
[35,38,41]) and on proteins involved in controlling the 
intracellular redox potential and/or the concentration 
of active chemical species (such as peroxides and 
superoxides [19]) also remain to be assessed.  
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